News

The pharmaceuticals sector is booming in the US, with the pandemic and the aging population being the key growth catalysts for the industry. The country is home to many leading pharma companies and accounts for about 22% of global...

Bios Health Group launches into the Life Science market to help biotech entrepreneurs and executives take their innovative ideas to the next level. This new company entity is a strategic partner providing end-to-end solutions for life science companies and...

Projected data suggests that the global expenditure on medications will reach $1.29 trillion by 2027i. This surge in spending has led to a heightened demand for contract manufacturing organizations (CMOs) to undertake aseptic fill-finish manufacturing agreements, particularly for parenteral...

Honeywell  and global contract development and manufacturing organization (CDMO) Recipharm have announced a commercial partnership that will speed the development of pressurized metered dose inhalers (pMDIs) that use Honeywell’s near-zero global warming potential (GWP) propellant. As many as 384 million...

The biopharmaceutical sector is undergoing a significant transformation in treating complex diseases, especially in oncology, driven by innovative drug approaches. This shift entails personalized therapies, combination treatments, and novel go-to-market strategies to address specific patient groups. As the industry...

Contract Development and Manufacturing Organizations (CDMOs), which pharmaceutical companies increasingly delegate product development and manufacturing, operate in a fragmented market undergoing substantial consolidation. Yet, many CDMOs fail to fully capitalize on pricing projects, risking competitiveness. To thrive, they must...

According to insights, the pharmaceutical CDMO market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.29% until 2028. This growth could be attributed to the expanding pharmaceutical sector, driven by the increasing usage of analytics...